Wuhu Fourth People's Hospital Trials

Wuhu Fourth People's Hospital	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

WANG, GANG

NCT05861063: The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

Recruiting

105

RoW

Fractional CO2 laser, paronosetron hydrochloride and lidocaine cream, Dezocine

Xijing Hospital

Acne Atrophica

12/23

12/24

NCT06355180: Esketamine Treatment for Depressive Episodes With Suicidal Ideation in Mood Disorders

Not yet recruiting

340

Subanesthetic dose intravenous esketamine, esketamine, Modified electroconvulsive therapy, MECT

Capital Medical University, Wuhu Fourth People's Hospital, The Second People's Hospital of Dali Bai Autonomous Prefecture, Inner Mongolia Autonomous Region Mental Health Center, Beijing Chaoyang District Third Hospital, Beijing Daxing District Xinkang Hospital, Capital's Funds for Health Improvement and Research

Mood Disorders, Suicidal Ideation, Depressive Episode

12/26

NCT04532229: Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children

Recruiting

RoW

Nimotuzumab+CRT(concurrent IMRT and TMZ), h-R3

Biotech Pharmaceutical Co., Ltd.

Diffuse Intrinsic Pontine Glioma

10/23

12/23

NCT05862337: Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Recruiting

480

RoW

Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Hepatocellular Carcinoma

08/24

12/26

NCT05772104: Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

Recruiting

495

RoW

Shugan Jieyu Capsules, Shugan Jieyu Capsules Placebo

Sichuan Jishengtang Pharmaceutical Co., Ltd.

Generalized Anxiety Disorder

02/25

06/25

NCT05093855: Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Completed

RoW

BDB-001 Injection

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Hidradenitis Suppurativa

08/23

NCT06259526: A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Recruiting

260

RoW

Placebo group, JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 low-dose group, JS1-1-01 pills; JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 pills; JS1-1-01 placebo pills, JS1-1-01 high-dose group, JS1-1-01 pills; Duloxetine hydrochloride placebo capsules, Active drug group, JS1-1-01 placebo pills; Duloxetine hydrochloride enteric coated capsule

Tasly Pharmaceutical Group Co., Ltd

Depression

04/25

NCT04388982: the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Recruiting

1/2

RoW

low dosage MSCs-Exos administrated for nasal drip, mild dosage MSCs-Exos administrated for nasal drip, high dosage MSCs-Exos administrated for nasal drip

Ruijin Hospital, Cellular Biomedicine Group Ltd.

Alzheimer Disease

08/21

08/22

NCT05103423: Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Completed

1/2

RoW

BDB-001 Injection, Placebo

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Hidradenitis Suppurativa

07/23

XYFY2021-KL184-01, NCT05211557: Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

Recruiting

1/2

RoW

fhB7H3.CAR-Ts

The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, IIT MediTech (Jiangsu) Co. Ltd

Ovarian Cancer

08/23

08/26

PM8002-A001, NCT05918445: PM8002 in the Treatment of Patients With Advanced Solid Tumors

Recruiting

1/2

380

RoW

PM8002

Biotheus Inc.

Malignant Neoplasm

11/25

NCT05323201: Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

Recruiting

1/2

RoW

fhB7H3.CAR-Ts, B7H3 targeting chimeric antigen receptor T cells, Fludarabine, FLUDARA, Cyclophosphamide, Cytoxan

The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, IIT MediTech Co. Ltd

Hepatocellular Carcinoma

02/24

02/27

KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies

Recruiting

1/2

1300

Canada, US, RoW

SKB264

Klus Pharma Inc.

Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer

08/25

07/26

NCT05196971: A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression

Completed

RoW

HS-10345 84mg, HS-10345, Placebo, HS-10345 Placebo

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Treatment Resistant Depressive Disorder

04/22

10/22

NCT06393803: Phase 1 Study of KH607 Tablets

Recruiting

RoW

2mg KH607 tablets, 5mg KH607 tablets, 10mg KH607 tablets, 20mg KH607 tablets, 30mg KH607 tablets, 40mg KH607 tablets, 50mg KH607 tablets, 60mg KH607 tablets

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Healthy

10/24

NCT06105151: Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Recruiting

RoW

VV119(SAD), VV119 Placebo(SAD), VV119(FE)

Vigonvita Life Sciences

Schizophrenia

12/24

NCT06674694: The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

Recruiting

RoW

Brexpiprazole long-acting injection

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Schizophrenia Disorders

06/25

NCT06504290: Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119

Recruiting

RoW

VV119 Placebo （in healthy adult subjects）, VV119 （in healthy adult subjects）, VV119(in adult patients with schizophrenia), VV119 Placebo （in adult patients with schizophrenia）

Vigonvita Life Sciences

Schizophrenia

07/25

NCT06556966: A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects

Not yet recruiting

LY03020, LPM787000048 Maleate sustained-release tablet, Placebo, Placebo of LPM787000048 Maleate sustained-release tablet

Luye Pharma Group Ltd.

Schizophrenia, Alzheimer's Disease Psychosis

05/25

08/25

MIMI, NCT06534658: Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia

Recruiting

N/A

1000

RoW

Ruijin Hospital

Alzheimer Disease, Image

07/29

08/29

NCT06552975: Clinical Study of Transcriptome-based Diagnostic Biomarker for Acute Febrile Illness

Recruiting

N/A

900

RoW

Infection

Qilu Hospital of Shandong University

Acute Febrile Illness

12/24

08/25

NCT06116162: Comparison of SVF-gel Filling and CO2 Fractional Laser on Atrophic Acne Scar Treatment

Completed

N/A

RoW

SVF-gel Filling and CO2 fractional laser

Xijing Hospital

Autologous Fat Graft Harvesting, SVF-gel Preparation and Filling, CO2 Fractional Laser Treatment by Using Acupulse Device

07/22

01/23

NCT05961605: COVID-19 Associated With Psoriasis

Recruiting

N/A

2500

RoW

Gang Wang, MD

Psoriasis Patients, COVID-19

05/23

07/23

NCT05228483: Carbon Dioxide（CO2）Fractional Laser Plus Photodynamic Therapy in Female Patients With Vulvar Lichen Sclerosus

Recruiting

N/A

134

RoW

CO2 fractional laser, 5-aminolevulinic acid (5-ALA) with red light illumination, Mometasone furoate (MMF) 0.1% ointment

Xijing Hospital

Vulva Lichen Sclerosus

11/23

06/24

NCT05827991: A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia

Recruiting

N/A

RoW

1565nm Non-ablative Fractional Laser, 5% minoxidil external use, 1565nm Non-ablative Fractional Laser combined with 5% minoxidil

Xijing Hospital

Androgenic Alopecia

12/23

BP, NCT06213909: Retrospective Study of the Effects of Sub-pathologic Phenotypes of on Clinical Management and Prognosis

Recruiting

N/A

318

RoW

This is a retrospective analysis of health data from inpatient record, no intervention was designed

Xijing Hospital

Bullous Pemphigoid

06/24

NCT05827913: Efficacy and Safety of Polylevolactic Acid Injection Combined With 1565nm Non-ablative Fractional Laser in the Treatment of Striae Distensae

Recruiting

N/A

RoW

Polylevolactic Acid Injection, 1565nm Non-ablative Fractional Laser, Polylevolactic Acid Injection combined with 1565nm Non-ablative Fractional Laser

Xijing Hospital

Striae Distensae

03/24

NCT06325527: Cognitive Impairment Cohort Study of the Elderly Population in YuGarden

Not yet recruiting

N/A

1872

RoW

Ruijin Hospital

Alzheimer Disease, Neurodegenerative Diseases, Cognitive Impairment, Mild Cognitive Impairment

04/31

06/31

NCT06692361: Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients with Major Depressive Disorder

Not yet recruiting

N/A

214

RoW

FMT capsule, microbiota capsule, FMT, Escitalopram (Lexapro), Escitalopram, Corn Starch capsules, Corn starch

Gang Wang, Shandong Daizhuang Hospital, Tianjin Anding Hospital, The First Affiliated Hospital, Zhejiang University, The First Hospital of Hebei Medical University, West China Hospital Affiliated with Sichuan University, Wuhu Fourth People's Hospital

Major Depressive Disorder (MDD), Depression - Major Depressive Disorder

06/26

12/26

COAST, NCT03653156: China Cognition and Aging Study

Recruiting

N/A

100000

RoW

Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Afﬁliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital

Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia

01/38

CFAN, NCT03657732: The Chinese Familial Alzheimer's Network

Recruiting

N/A

40000

RoW

Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Afﬁliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital

Alzheimer Disease, Familial Alzheimer Disease (FAD)

01/38

NCT05201521: Chinese FMDs Registry

Not yet recruiting

N/A

100

RoW

Ruijin Hospital

Functional Movement Disorders

08/23

01/24

SHARAD, NCT05597410: Shanghai At Risk for Alzheimer's Disease: a Cohort Study

Recruiting

N/A

3418

RoW

Ruijin Hospital

Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment, Neurocognitive Disorders

03/29

03/30

SheMountain, NCT05667935: Cognitive Impairment Cohort Study of the Elderly Population in

Not yet recruiting

N/A

2000

RoW

Ruijin Hospital

Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment, Mild Cognitive Impairment

12/30

01/31



	Diseases Companies Products Productz Mechanisms of Action Sites